Nikhil Patel
About Nikhil Patel
Nikhil Patel is the Founder and CEO of Craniometrix and a member of the Steering Committee for Dementia at the Milken Institute. He studied Computer Science and Economics at Yale University and aims to develop a telemedicine platform specifically for Alzheimer's disease.
Work at Craniometrix
Nikhil Patel serves as the Founder and CEO of Craniometrix, a company that is part of the Y Combinator W22 batch. He has held this position since 2022, contributing to the company's mission and strategic direction for two years. Under his leadership, Craniometrix focuses on developing innovative solutions in the healthcare sector, particularly in relation to neurological conditions.
Current Role at Milken Institute
In addition to his role at Craniometrix, Nikhil Patel is a member of the Steering Committee for Dementia at the Milken Institute. He has been involved in this position since 2024, contributing to initiatives aimed at addressing challenges related to dementia. His work at the Milken Institute aligns with his interests in healthcare and technology.
Education and Expertise
Nikhil Patel studied at Yale University, where he earned a Bachelor of Science in Computer Science and a Bachelor of Arts in Economics. His academic tenure spanned from 2017 to 2021, during which he developed a strong foundation in both technical and economic principles. This educational background supports his endeavors in the tech and healthcare industries.
Background
Nikhil Patel is a Yale alumnus with a dual degree in Computer Science and Economics. His educational experiences have equipped him with a diverse skill set that he applies in his professional pursuits. He is based in New York, New York, and is actively engaged in initiatives that aim to improve healthcare delivery, particularly for Alzheimer’s disease.
Future Aspirations
Nikhil Patel aims to build a telemedicine platform specifically designed for Alzheimer’s disease. This initiative reflects his commitment to leveraging technology to enhance patient care and accessibility in the healthcare sector. His vision aligns with current trends in telemedicine and the growing need for specialized healthcare solutions.